KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insulet (PODD) Cash & Equivalents (2016 - 2025)

Insulet's Cash & Equivalents history spans 16 years, with the latest figure at $716.1 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 24.89% year-over-year to $716.1 million; the TTM value through Dec 2025 reached $716.1 million, down 24.89%, while the annual FY2025 figure was $716.1 million, 24.89% down from the prior year.
  • Cash & Equivalents reached $716.1 million in Q4 2025 per PODD's latest filing, down from $757.4 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.3 billion in Q1 2025 to a low of $620.7 million in Q1 2023.
  • Average Cash & Equivalents over 5 years is $805.8 million, with a median of $754.3 million recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: soared 307.5% in 2021, then dropped 24.89% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $791.6 million in 2021, then fell by 14.77% to $674.7 million in 2022, then increased by 4.37% to $704.2 million in 2023, then soared by 35.39% to $953.4 million in 2024, then decreased by 24.89% to $716.1 million in 2025.
  • Per Business Quant, the three most recent readings for PODD's Cash & Equivalents are $716.1 million (Q4 2025), $757.4 million (Q3 2025), and $1.1 billion (Q2 2025).